Endo Pharmaceuticals, Inc. recalls robaxin-750 (methocarbamol tablets, USP), 750 mg, 100-count bottle, Rx Only, Distributed by: Endo Pharmaceuticals Inc.,
Endo Pharmaceuticals recalls Robaxin 750mg tablets due to incorrect dosage instructions on labels. This could lead to unsafe dosing if users follow the wrong label instructions.
Lower-risk recall
Labeling: Incorrect Instructions: Dosage information on the immediate container label incorrectly states "Two to four tablets four times daily." rather than the correct dosage of "Two tablets three times daily."
Contact the company & request your remedy
What happened, in plain English
Endo Pharmaceuticals is recalling Robaxin 750mg tablets because the label incorrectly states "two to four tablets four times daily" instead of "two tablets three times daily." This could lead to taking too many pills and potential overdose risk. Read more at govinfonow.com/recall/39564-endo-robaxin-750mg-tablets-incorrect-dosage-label-recall.
Source Summary by GovInfoNow · govinfonow.com/recall/39564-endo-robaxin-750mg-tablets-incorrect-dosage-label-recall · Updated October 6, 2026 · FDA enforcement record: FDA #D-0009-2019
Cite this page
“Endo Robaxin 750mg Tablets: Incorrect Dosage Label Recall.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/39564-endo-robaxin-750mg-tablets-incorrect-dosage-label-recall. Based on FDA recall #D-0009-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0009-2019%22&limit=1).
Why it’s dangerous
The label shows incorrect dosage instructions that could lead to taking more medication than intended. This might cause an overdose if users follow the wrong label instructions.
Who’s affected
Prescription holders of Robaxin 750mg tablets with the specific lot numbers mentioned in the recall. Patients who self-medicate or use the product without a prescription are not affected.
How to tell if you have this one
Check for Robaxin 750mg tablets with lot numbers 216702P1 (expiring September 2020) or 220409P1 (expiring January 2021). The product is only available by prescription.
- Brand
Endo Pharmaceuticals- Category
Drug
What to do — step by step
Check Label Instructions
Review the dosage instructions on the label to ensure they match the correct dosage of two tablets three times daily.
Questions people ask
Is this product safe to use?
The product is safe to use if the dosage instructions are followed correctly. However, the label has incorrect instructions that could lead to unsafe dosing.
What should I do if I have the recalled product?
The recall does not specify a remedy, so users should check the label instructions and contact their healthcare provider if they have concerns.
Are there any specific lot numbers I should avoid?
Yes, avoid lot numbers 216702P1 (expiring September 2020) and 220409P1 (expiring January 2021).
Contact Endo Pharmaceuticals
We’ve drafted a message you can send Endo Pharmaceuticals to request your refund or repair — edit it as you like.
Subject: Recall D-0009-2019 — Endo Pharmaceuticals Endo Pharmaceuticals Hello, I own a Endo Pharmaceuticals that is covered by recall D-0009-2019 from Endo Pharmaceuticals. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0009-2019 (September 17, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0009-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.